Allergy/Imm Medical News about urticaria

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg
Journal of the European Academy of Dermatology and Venereology, 08/10/09

Giménez–Arnau A et al. – The results support the use of higher than standard doses of non sedating antihistamines in chronic urticaria. The authors strongly recommend performing and reporting responder analyses for established and new drugs used by patients with chronic urticaria.

<< Previous
Vascular damage in giant cell arteritis

Next >>
Daily family assistance and inflammation among adolescents from...

The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Allergy, 11/16/09 Relevance Score: 88%

Solar urticaria
Allergy and Asthma Proceedings, 10/12/09 Relevance Score: 88%

Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection
Journal of Clinical Epidemiology, 11/09/09 Relevance Score: 87%

Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria
British Journal of Dermatology, 10/05/09 Relevance Score: 87%

Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up
Clinical and Experimental Dermatology, 11/02/09 Relevance Score: 84%